BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Distribution Rights Of BELBUCA(R) In Canada

RALEIGH, N.C. and PICKERING, Ontario, July 12, 2017 -- (Healthcare Sales & Marketing Network) -- Today, BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, and... Biopharmaceuticals, Licensing, Distribution BioDelivery Sciences, Purdue Pharma, BELBUCA, buprenorphine buccal
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news